Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

ALBT

Avalon GloboCare (ALBT)

Avalon GloboCare Corporation
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:ALBT
DateHeureSourceTitreSymboleSociété
15/05/202414h00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:ALBTAvalon GloboCare Corporation
07/05/202422h30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:ALBTAvalon GloboCare Corporation
22/04/202415h00GlobeNewswire Inc.Avalon GloboCare Announces Launch of U.S. Sales of KetoAir Breathalyzer at the Hack Your Health by KetoCon 2024 ConferenceNASDAQ:ALBTAvalon GloboCare Corporation
28/03/202414h00GlobeNewswire Inc.Avalon GloboCare Extends Exclusivity Agreement to Distribute KetoAir Breathalyzer Device and AI-Enabled Software in North America, South America, United Kingdom and European UnionNASDAQ:ALBTAvalon GloboCare Corporation
18/12/202315h00GlobeNewswire Inc.Avalon GloboCare Engages ChtrBx, a Marketing and Branding Company, to Launch KetoAir in the USNASDAQ:ALBTAvalon GloboCare Corporation
14/11/202322h30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:ALBTAvalon GloboCare Corporation
20/10/202322h18Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:ALBTAvalon GloboCare Corporation
18/10/202315h00GlobeNewswire Inc.Avalon GloboCare Partners with Qi Diagnostics to Co-Develop International Multi-Center Clinical Studies for DKAir Breathalyzer Device for the Early Detection of Diabetic KetoacidosisNASDAQ:ALBTAvalon GloboCare Corporation
04/10/202315h00GlobeNewswire Inc.Apple Approves Use of Avalon GloboCare’s KetoAir Mobile ApplicationNASDAQ:ALBTAvalon GloboCare Corporation
13/09/202315h15GlobeNewswire Inc.Avalon’s Laboratory Services MSO Acquires California-Based Medical Supply Company and Proprietary FDA-Registered External Male Catheter DeviceNASDAQ:ALBTAvalon GloboCare Corporation
08/09/202323h21Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:ALBTAvalon GloboCare Corporation
08/09/202323h19Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:ALBTAvalon GloboCare Corporation
05/09/202317h46AllPennyStocks.comNews Brief: Avalon GloboCare Corp.NASDAQ:ALBTAvalon GloboCare Corporation
05/09/202314h00GlobeNewswire Inc.Avalon GloboCare Announces Notice of Publication for Key U.S. Patent Filed Jointly with the Massachusetts Institute of Technology (MIT)NASDAQ:ALBTAvalon GloboCare Corporation
30/08/202315h00GlobeNewswire Inc.Avalon’s Laboratory Services MSO Launches Innovative Laboratory Test for TuberculosisNASDAQ:ALBTAvalon GloboCare Corporation
29/08/202322h55Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:ALBTAvalon GloboCare Corporation
21/08/202315h00GlobeNewswire Inc.Avalon’s Laboratory Services MSO Announces Expansion into ArizonaNASDAQ:ALBTAvalon GloboCare Corporation
24/07/202315h00GlobeNewswire Inc.Avalon’s Laboratory Services MSO Acquires Texas Lab with Significant Potential GrowthNASDAQ:ALBTAvalon GloboCare Corporation
19/07/202315h00GlobeNewswire Inc.Avalon GloboCare’s Laboratory Services MSO Signs Exclusive In-Network Lab Services Agreement Providing Significant Expansion Opportunity into 21 StatesNASDAQ:ALBTAvalon GloboCare Corporation
10/07/202315h00GlobeNewswire Inc.Avalon GloboCare Provides Update on New Commercial StrategyNASDAQ:ALBTAvalon GloboCare Corporation
29/06/202322h32Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:ALBTAvalon GloboCare Corporation
29/06/202322h31Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:ALBTAvalon GloboCare Corporation
29/06/202312h05Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:ALBTAvalon GloboCare Corporation
29/06/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:ALBTAvalon GloboCare Corporation
26/05/202323h08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:ALBTAvalon GloboCare Corporation
26/05/202313h01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:ALBTAvalon GloboCare Corporation
22/05/202322h16Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:ALBTAvalon GloboCare Corporation
16/05/202314h58Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)NASDAQ:ALBTAvalon GloboCare Corporation
27/04/202315h00GlobeNewswire Inc.Avalon GloboCare Reports Laboratory Services MSO Revenue of $14.7 Million and Net Income of $6.3 Million in 2022NASDAQ:ALBTAvalon GloboCare Corporation
17/04/202315h00GlobeNewswire Inc.Avalon GloboCare Announces Commercial Launch of KetoAir Breathalyzer at the KetoCon Austin 2023 ConferenceNASDAQ:ALBTAvalon GloboCare Corporation
 Showing the most relevant articles for your search:NASDAQ:ALBT